Evidence map›Paper›PMID 26380181›Full record

ReviewTranslational lung cancer research2015

Computer modeling of lung cancer diagnosis-to-treatment process.

Feng Ju, Hyo Kyung Lee, Raymond U Osarogiagbon, Xinhua Yu, Nick Faris, Jingshan Li

Abstract readReview
In one paragraph

Review in Translational lung cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feng Ju1 Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI 53706, USA ; 2 Thoracic Oncology Research Group, Baptist Memorial Health System, Memphis, TN, USA ; 3 School of Public Health, University of Memphis, Memphis, TN, USA.
Hyo Kyung Lee1 Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI 53706, USA ; 2 Thoracic Oncology Research Group, Baptist Memorial Health System, Memphis, TN, USA ; 3 School of Public Health, University of Memphis, Memphis, TN, USA.
Raymond U Osarogiagbon1 Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI 53706, USA ; 2 Thoracic Oncology Research Group, Baptist Memorial Health System, Memphis, TN, USA ; 3 School of Public Health, University of Memphis, Memphis, TN, USA.
Xinhua Yu1 Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI 53706, USA ; 2 Thoracic Oncology Research Group, Baptist Memorial Health System, Memphis, TN, USA ; 3 School of Public Health, University of Memphis, Memphis, TN, USA.
Nick Faris1 Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI 53706, USA ; 2 Thoracic Oncology Research Group, Baptist Memorial Health System, Memphis, TN, USA ; 3 School of Public Health, University of Memphis, Memphis, TN, USA.
Jingshan Li1 Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI 53706, USA ; 2 Thoracic Oncology Research Group, Baptist Memorial Health System, Memphis, TN, USA ; 3 School of Public Health, University of Memphis, Memphis, TN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We introduce an example of a rigorous, quantitative method for quality improvement in lung cancer care-delivery. Computer process modeling methods are introduced for lung cancer diagnosis, staging and treatment selection process. Two types of process modeling techniques, discrete event simulation (DES) and analytical models, are briefly reviewed. Recent developments in DES are outlined and the necessary data and procedures to develop a DES model for lung cancer diagnosis, leading up to surgical treatment process are summarized. The analytical models include both Markov chain model and closed formulas. The Markov chain models with its application in healthcare are introduced and the approach to derive a lung cancer diagnosis process model is presented. Similarly, the procedure to derive closed formulas evaluating the diagnosis process performance is outlined. Finally, the pros and cons of these methods are discussed.

Indexed as

analytical modelclosed formuladiscrete event simulation (DES)Lung cancer quality improvementMarkov chainprocess modeling

Identifiers

PMID26380181
PMCPMC4549484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.